Intellia Therapeutics Cash from Financing (TTM) Trends

Intellia Therapeutics Inc (NTLA)

21.32 -0.18 (-0.84%) USD | NASDAQ | Apr 18, 16:00

21.21 -0.11 (-0.52%) Pre-Market: 09:27

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2015. Upgrade now.

Date	Value
December 31, 2023	130.32M
September 30, 2023	529.60M
June 30, 2023	534.48M
March 31, 2023	537.86M
December 31, 2022	582.96M
September 30, 2022	79.47M
June 30, 2022	724.18M
March 31, 2022	725.41M
December 31, 2021	736.69M
September 30, 2021	968.50M
June 30, 2021	300.42M
March 31, 2021	425.51M
December 31, 2020	371.78M
September 30, 2020	157.25M
June 30, 2020	203.05M
March 31, 2020	77.30M
December 31, 2019	76.43M

Date	Value
September 30, 2019	87.03M
June 30, 2019	42.81M
March 31, 2019	37.50M
December 31, 2018	40.22M
September 30, 2018	152.17M
June 30, 2018	150.36M
March 31, 2018	149.65M
December 31, 2017	142.98M
September 30, 2017	1.125M
June 30, 2017	-1.10M
March 31, 2017	168.55M
December 31, 2016	167.30M
September 30, 2016	166.59M
June 30, 2016	235.16M
March 31, 2016	64.76M
December 31, 2015	70.29M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

42.81M

Minimum

Jun 2019

968.50M

Maximum

Sep 2021

383.74M

Average

371.78M

Median

Dec 2020

Cash from Financing (TTM) Benchmarks